Staged Laparoscopic Sleeve Gastrectomy Followed by Roux-en-Y Gastric Bypass for Morbidly Obese Patients: A Risk Reduction Strategy
In our centre laparoscopic Roux-en-Y gastric bypass (LRYGBP) is the most effective weight loss surgical procedure performed. However, LRYGBP may be associated with higher risk of peri- and postoperative complications in contrast to a purely restrictive procedure to justify this procedure on all comers. Laparoscopic sleeve gastrectomy (LSG) as a staged procedure may be an alternate risk reduction strategy. The aim of this study is to report on the short-term outcomes of LSG, the effect on operative risk reduction and resolution of comorbidities.
A prospective review of 138 patients who underwent consecutive LSG from November 2004 to November 2006 was performed. Data were collected on all patients who attended the three to six monthly clinical follow-up and/or the patient questionnaire. Data collection included demographics, degree of weight reduction, postoperative complications, and changes in comorbidities.
Median BMI was 50.60 kg/m2 (33–82). Of the patients, 46.38% had a BMI ≥50 kg/m2. The overall median postoperative excess weight loss (EWL) was 43.26%, 31.08% at 6 months, 54.50% at 12 months, 51.47% at 18 months and 46.05% at 24 months. Of the patients, 39% had resolution of type 2 diabetes mellitus, 48% had resolution of dyslipidemia, 29% in hypertension, 52% in obstructive sleep apnea. Complication rate was 5.07% and four patients needed further surgical intervention. The mortality rate was zero.
LSG does minimize postoperative complication rates significantly on high-risk patients and achieves effective short-term weight loss with resolutions in comorbidities. Additional studies are required to evaluate LSG as a stand-lone procedure.
KeywordsLaparoscopy Sleeve gastrectomy Morbid obesity LSG Risk reduction
- 2.National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults. Canberra: NHMRC, September 2003. Available at: www.health.gov.au/internet/wcms/publishing.nsf/Content/obesityguidelines-guidelines-adults.htm/$FILE/adults.pdf (accessed Feb 2005). (July 2007).
- 3.Clegg A, Sidhu MK, Colquitt J, et al. Clinical and cost effectiveness of surgery for people with morbid obesity. Southampton: National Institute for Clinical Excellence, 2001. Available at: www.nice.org.uk/pdf/AssessmentReport-Surgeryforobesity.pdf (accessed Mar 2005). (July 2007).
- 4.NHS National Institute for Clinical Excellence. Guidance on the use of surgery to aid weight reduction for people with morbid obesity. Technology Appraisal Guidance No. 46. London: NICE, July 2002. Available at: www.nice.org.uk/pdf/Fullguidance-PDF-morbid.pdf (accessed Feb 2005).
- 5.US National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: NHLBI, 1998. Available at: www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm (accessed Feb 2005).
- 7.Gallagher SF, Banasiak M, Gonzalvo JP, et al. The impact of bariatric surgery on the Veterans Administration healthcare system: a cost analysis. Obes Surg. 2003;13:245–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12740132&dopt=Abstract \t 11.Google Scholar
- 8.Craig BM, Teng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113:491–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12427499&dopt=Abstract \t 12.Google Scholar
- 13.DeMaria et al. Validation of the Obesity Surgery Mortality Risk Score (OS-MRS) In A Multi-Center Study Proves It Stratifies Mortality Risk In Patients Undergoing Gastric Bypass (GBP) For Morbid Obesity. ASA: 2007 Abstracts. Colorado Springs.Google Scholar
- 18.Colles S, Dixon J, O’Brien P. A prospective study of the effect of a 12-week very low calorie diet on changes in health status, liver size and abdominal adipose tissue in the severely obese. Asia Pac J Clin Nutr. 2005;14 Suppl:S60.Google Scholar